Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of stem cell in preparation of preparation used for treating parkinson disease

A Parkinson's disease, stem cell technology, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve the problems of patients with postural reflex loss, difficulty in obtaining materials, balance disorders, etc., to achieve low immune response risk, active High, low residual effect

Active Publication Date: 2014-12-17
SHENZHEN BEIKE BIOTECH +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

③. Finally, the patient suffers from loss of postural reflexes, balance disturbance and even falls
However, embryonic stem cell research has always been a controversial field because of ethical issues, and its sources are restricted by ethics and morality, making it difficult to obtain materials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of stem cell in preparation of preparation used for treating parkinson disease
  • Application of stem cell in preparation of preparation used for treating parkinson disease
  • Application of stem cell in preparation of preparation used for treating parkinson disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] 1. Stripping of umbilical cord Wharton's jelly

[0063] Immediately after the fetus was delivered, the umbilical cord was ligated and cut according to the obstetrical routine, the umbilical cord was washed with normal saline, and then disinfected with medical alcohol, and the umbilical cord was stored in the umbilical cord preservation solution at a constant temperature of 2-8°C.

[0064] The obtained umbilical cord was rinsed with 0.9% sodium chloride injection, and repeated 2 to 3 times to remove blood stains. The whole umbilical cord was sterilized by immersing it in 75% ethanol. Sodium chloride injection was washed repeatedly to remove residual ethanol. Use sterile surgical scissors to cut the umbilical cord into several sections of about 2 to 5 cm, and remove the congestion and clots in the blood vessels of the small section of the umbilical cord. Remove two arteries and one vein from the umbilical cord. The white connective tissue located between the amniotic m...

Embodiment 2

[0077] 1. Passage and culture of P0 generation cells

[0078] The cell suspension was centrifuged at 300g for 10min. Discard the supernatant, resuspend the cells by gently pipetting with fresh medium, and follow the 5×10 3 piece / cm 2 Density inoculation and passage. Each T175 flask was inoculated with cell suspension, and fresh medium was added. Place in a carbon dioxide constant temperature and humidity incubator to start culturing. Conditions: 37.0±0.5°C, carbon dioxide volume fraction 5.0±0.2%.

[0079] 2. Cell passage

[0080] Cells were cultured for 72±24 hours, and after the cell confluence was observed under an inverted microscope to reach 80%-90%, they could be digested and harvested to obtain P1 generation cells.

[0081] 2.1 Digestion

[0082] Transfer the old culture medium to a sterile container (such as a T175 culture bottle) for later use. Rinse the culture bottle gently with an appropriate amount of 0.9% sodium chloride injection, and discard the washing...

Embodiment 3

[0103] 1. Recovery of cells

[0104] Take out the frozen cells from the liquid nitrogen tank, put them on the recovery rack in the electric heating constant temperature water tank (the water temperature is kept at about 40.0°C), and shake quickly to rewarm. Resuscitation is complete when the cell suspension changes from solid to liquid.

[0105] 1.1 Cell washing:

[0106] Combine the cell suspension into a centrifuge tube. Add pre-cooled 0.9% sodium chloride injection, blow and wash the pipette, constant volume, mix, centrifuge, 300g, 10min.

[0107] 1.2 Sampling counting and washing:

[0108] Discard the washing supernatant, resuspend the cell pellet in an appropriate amount of pre-cooled 0.9% sodium chloride injection, combine it into a centrifuge tube, send the sample to detect the total number of cells and cell viability, centrifuge the cell suspension at 300g, 10min, discard the upper cleared to obtain P3 generation cells.

[0109] 1.3 Passage and cultivation:

[01...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of an umbilical cord mesenchymal stem cell in preparation of a preparation used for treating parkinson disease, and also provides a method for preparing a umbilical cord mesenchymal stem cell for a preparation used for treating parkinson disease, and a preparation composition with the stem cell. The prepared umbilical cord mesenchymal stem cell has the advantages of low immunoreactions risk, high activity, low residues, low preparation cost, and the like.

Description

technical field [0001] The invention relates to the field of stem cell preparation for treating diseases. Specifically, the present invention provides a use of umbilical cord mesenchymal stem cells in preparing a preparation for treating Parkinson's disease. Background technique [0002] Parkinson's Disease (PD), or Parkinson's disease, is a neurodegenerative disease characterized by progressive loss of striatal dopaminergic neuron function. In 1817 James Parkinson described two paradoxical symptoms in Parkinson's Disease (PD) - tremor and paralysis, with myotonia being the third major symptom. PD is a common disease of basal ganglia damage. The degeneration and loss of dopaminergic neurons in the substantia nigra-striatal system in the basal ganglia lead to a decrease in dopamine levels, hyperfunction of the acetylcholine system, and hyperactivity of the subthalamic nucleus and medial globus pallidum. Excitement and increased muscle tone are the main pathophysiological ba...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0775A61K35/44A61P25/16A61K35/28
Inventor 王小洪胡祥刘沐芸刘强
Owner SHENZHEN BEIKE BIOTECH